Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme

Gordon, Louisa, Youl, Philippa H., Elwood, Mark, Janda, Monika, Ring, Ian T., Lowe, John B., & Aitken, Joanne F. (2007) Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme. Journal of Medical Screening, 14(2), pp. 98-102.

View at publisher


Background: Recently, massive increases in health-care costs for the diagnosis and management of skin lesions have been observed (2000–05). The aim of this study was to describe the health system costs attributed to the diagnosis and management of suspicious skin lesions detected during a trial of a population melanoma screening programme (1998–2001).

Setting: Queensland, Australia.

Methods: Data from the trial and Medicare Australia were used to categorize and cost all suspicious skin lesions arising from the trial, which included general practitioner consultations, diagnosis/management and pathology. Comparisons were made with other screened and unscreened populations.

Results: Overall, 2982 lesions were treated within the trial producing a mean cost of Aus$118 per lesion. Excisions for benign lesions contributed the greatest proportion of total costs (45%). The total cost burden was approximately 10% higher for men than women, and 63% of overall costs were for persons aged ≥50 years. For diagnosis and management procedures, the estimated average cost per 1000 individuals was Aus$23,560 for men aged ≥50 years from the skin cancer screening trial, compared with Aus$26,967 for BreastScreen Australia and Aus$3042 for the National Cervical Screening Program.

Conclusions: The proportion of costs for benign skin lesions and biopsies arising from the screening programme were no higher than in the two-year period outside the trial. While comparisons are difficult, it appears that diagnostic and management costs for skin cancer as a result of screening may be comparable with those for BreastScreen Australia, if screening is targeted at men aged 50 years.

Impact and interest:

7 citations in Scopus
Search Google Scholar™
4 citations in Web of Science®

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

Full-text downloads:

399 since deposited on 15 Sep 2008
57 in the past twelve months

Full-text downloads displays the total number of times this work’s files (e.g., a PDF) have been downloaded from QUT ePrints as well as the number of downloads in the previous 365 days. The count includes downloads for all files if a work has more than one.

ID Code: 14848
Item Type: Journal Article
Refereed: Yes
DOI: 10.1258/096914107781261963
ISSN: 1475-5793
Divisions: Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
Copyright Owner: Copyright 2007 Royal Society of Medicine Press
Copyright Statement: This is the final draft, after peer-review, of a manuscript published in [Journal of Medical Screening]. The definitive version, detailed above, is available online at www.rsmjournals.com. Please note that access controls may apply. If you would like further information please contact us at rsmjournals@rsm.ac.uk
Deposited On: 15 Sep 2008 00:00
Last Modified: 29 Feb 2012 13:38

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page